APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.
BACKGROUND
Apolipoprotein E is polymorphic in the human population. APOE4 has previously been reported to correlate with symptomatic oral and genital herpes disease.


METHODS
APOE was genotyped in 182 subjects with herpes simplex virus (HSV) 2 and in 62 subjects with HSV-1, including 44 subjects with both viral types for a total of 200 adults. HSV shedding was measured by PCR from swab samples obtained daily from mucosa for at least 30 days. Participants also maintained a diary of oral or genital lesions.


RESULTS
The APOE genotypes observed reflected the US white population and the Hardy-Weinberg equilibrium. Genital and oral HSV shedding was detected on 17.2% and 3.7% of overall days, respectively, whereas genital and oral lesion rates were 10.1% and 2.9%. Using Poisson regression and adjusting for known correlates of HSV shedding, a significant association was not observed between the APOE genotype and genital or oral HSV shedding, or genital HSV lesions. However, the presence of the APOE4 allele was associated with a higher rate of oral herpetic lesions, with a relative risk of 4.64 (95% CI 1.32 to 15.05, p=0.016).


CONCLUSIONS
Variation at the APOE locus may be associated with clinical manifestations of HSV-1 infection, but does not appear to correlate with herpes simplex viral reactivation in humans.
Koelle
David M
DM
Department of Medicine, University of Washington, Seattle, Washington 98102, USA. viralimm@u.washington.edu
Magaret
Amalia
A
Warren
Terri
T
Schellenberg
Gerard D
GD
Wald
Anna
A
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D001057:Apolipoproteins E / Q000235:genetics*; D004279:DNA, Viral / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006558:Herpes Genitalis / Q000235:genetics* / Q000821:virology; D018259:Herpesvirus 1, Human / Q000235:genetics* / Q000502:physiology; D018258:Herpesvirus 2, Human / Q000235:genetics* / Q000502:physiology; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D011379:Prognosis; D013283:Stomatitis, Herpetic / Q000235:genetics* / Q000821:virology; D051195:Toll-Like Receptor 2 / Q000235:genetics; D017201:Virus Shedding
D000914:Antibodies, Viral; D001057:Apolipoproteins E; D004279:DNA, Viral; D051195:Toll-Like Receptor 2
J Clin Microbiol. 1988 Apr;26(4):662-7
2835389
J Virol. 2006 Jun;80(11):5383-7
16699018
Clin Chem Lab Med. 2003 May;41(5):628-31
12812258
J Infect Dis. 2008 Aug 15;198(4):624-5; author reply 625-6
18652551
Lancet. 1997 Jan 25;349(9047):241-4
9014911
J Clin Microbiol. 2002 Jul;40(7):2609-11
12089286
Aging Cell. 2007 Dec;6(6):841-2
17725689
Sex Transm Infect. 2008 Dec;84(7):516-7
18708484
J Clin Microbiol. 2007 May;45(5):1618-20
17329447
Neuroreport. 2003 Oct 6;14(14):1825-7
14534428
Sex Transm Infect. 2009 Aug;85(4):270-5
19211593
Ann Intern Med. 1992 Mar 15;116(6):433-7
1310837
J Virol. 2002 Dec;76(23):12394-8
12414984
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):E87
19004794
Am J Hum Genet. 2000 Oct;67(4):881-900
10986041
J Med Virol. 2005 Jul;76(3):350-5
15902702
Yale J Biol Med. 2003;76(2):79-80
15369635
J Virol. 1999 Nov;73(11):8950-7
10516000
J Infect Dis. 2007 May 1;195(9):1324-31
17397003
J Infect Dis. 2006 Aug 15;194(4):420-7
16845624
J Alzheimers Dis. 2008 Apr;13(3):255-66
18430993
J Infect Dis. 2007 Aug 15;196(4):505-9
17624834
Cell. 2008 Mar 21;132(6):935-44
18358807
N Engl J Med. 2000 Mar 23;342(12):844-50
10727588
JAMA. 2006 Aug 23;296(8):964-73
16926356
Med Clin North Am. 2002 May;86(3):591-614
12171060
Ann Hum Biol. 2006 May-Jun;33(3):279-308
17092867
Science. 1990 Nov 30;250(4985):1262-6
2173860
Immunity. 1998 Jan;8(1):21-30
9462508
Neurobiol Aging. 2008 Jan;29(1):71-7
17101197
Nature. 1995 Jun 1;375(6530):411-5
7760935
J Infect Dis. 2008 Feb 1;197(3):340-6
18199027